ExamPat

Sharon L Turner

USPTO Patent Examiner·Active 2012 to 2023

Sharon L Turner is a USPTO patent examiner who has handled 55 ex parte reexaminations between 2012 and 2023. These reexams concentrate in Chemistry & Materials, Life Sciences & Consumer, and Physics & Instruments. ExamPat indexes the full prosecution record for each of these cases, including office-action grounds, certificate outcomes, and downstream PTAB and federal-circuit decisions.

Filings by year

6
12
4
13
5
14
9
15
5
16
3
17
3
18
6
19
4
20
3
21
4
22
3
23

Technology mix

Chemistry & Materials43 (78%)
Life Sciences & Consumer8 (15%)
Physics & Instruments3 (5%)
Mechanical & Manufacturing1 (2%)

Compare against all examiners

Eight side-by-side metrics: case volume, pendency, OAs per reexam, rejection mix, SNQ denial rate, certification rate, and PTAB appeal rate, with a Δ column showing where this examiner runs higher or lower than the corpus.

  • Average and median pendency, both for this examiner and the corpus
  • Rejection basis split (102 / 103 / 112) head-to-head
  • Certification, SNQ denial, and PTAB appeal rates

Certificate outcome distribution

How this examiner's certificates split across the six possible outcomes: all claims confirmed, confirmed with amendment, confirmed with new claims, mixed, or all claims canceled. Includes share comparison to the corpus distribution.

  • Count and share for each of the six outcome buckets
  • Δ vs. corpus distribution in percentage points
  • Useful for setting realistic patent-owner expectations

Event-to-event timing

Median time for this examiner's cases at each prosecution stage, from filing to first office action, filing to NIRC, and filing to certificate, with corpus comparison and sample size.

  • Median in months per transition
  • Side-by-side with the corpus median
  • n column showing how many of this examiner's cases completed each transition

vs. all examiners

Certificate outcome distribution

Event-to-event timing (median)

Recent reexaminations (showing 25 of 55)

View all in dashboard →
Control #FiledPatentTitlePendencyStatus
90/019,321Dec 5, 20238,609,935SOYBEAN EVENT DP-305423-1 AND COMPOSITIONS AND METHODS FOR THE IDENTIFICATION AND/OR DETECTION THEREOF15 moClosed
90/019,319Dec 1, 20237,838,733NOVEL HERBICIDE RESISTANCE GENES17 moClosed
90/019,229Jul 19, 202310,463,049ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA15 moClosed
90/019,139Dec 9, 20229,695,439METHODS FOR GENETIC CONTROL OF INSECT INFESTATIONS IN PLANTS AND COMPOSITIONS THEREOF13 moClosed
90/019,138Dec 4, 20227,632,985SOYBEAN EVENT MON89788 AND METHODS FOR DETECTION THEREOF13 moClosed
90/019,131Nov 18, 20228,283,522NOVEL HERBICIDE RESISTANCE GENES28 moClosed
90/015,055Jun 24, 20228,465,937METHODS FOR IDENTIFYING B-CLONES WHICH BIND CELL-SURFACE ANTIGENS15 moClosed
90/014,907Nov 19, 20219,783,791Mutant Reverse Transcriptase and Methods of Use—Closed
90/014,882Oct 15, 202110,774,309Natural killer cell immunotherapy for treating cancer17 moClosed
90/014,681Feb 16, 202110,920,222TREATING AND PREVENTING MICROBIAL INFECTIONS7 moClosed
90/014,582Sep 21, 202010,179,938ARTIFICIAL SELECTION METHOD AND REAGENTS39 moClosed
90/014,573Sep 15, 20208,999,291Compositions and Methods for the Removal of Biofilms18 moClosed
90/014,448Feb 11, 202010,464,992VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION59 moClosed
90/014,428Jan 2, 20209,550,834Methods for Preparing Glycan-Hydrolyzed Antibody, and Homogeneous Glycosylated Antibody14 moClosed
90/014,394Oct 23, 20199,675,668Modified Polynucleotides Encoding Hepatitis A Virus Cellular Receptor 232 moClosed
90/014,365Aug 12, 20199,534,234ENHANCED NUCLEIC ACID CONSTRUCTS FOR EUKARYOTIC GENE EXPRESSION54 moClosed
90/014,353Aug 2, 20199,511,092CHIMERIC RECEPTOR WITH NKG2D SPECIFICITY FOR USE IN CELL THERAPY AGAINST CANCER AND INFECTIOUS DISEASE13 moClosed
90/014,319Jun 19, 20199,580,697ENHANCED NUCLEIC ACID CONSTRUCTS FOR EUKARYOTIC GENE EXPRESSION15 moClosed
90/014,296May 1, 20199,567,577Expression Vector Comprising A Polynucleotide Encoding A Modified Glutamine Synthetase And A Method For Preparing A Target Protein Employing the Same11 moClosed
90/014,290Apr 19, 20199,926,574WIDESPREAD GENE DELIVERY TO MOTOR NEURONS USING PERIPHERAL INJECTION OF AAV VECTORS11 moClosed
90/014,175Aug 1, 20189,511,092CHIMERIC RECEPTOR WITH NKG2D SPECIFICITY FOR USE IN CELL THERAPY AGAINST CANCER AND INFECTIOUS DISEASE49 moClosed
90/014,159Jun 29, 20188,703,485GERM CELLS HAVING INACTIVATED ENDOGENEOUS IMMUNOGLOBULIN GENES, AND TRANSGENIC ANIMALS DERIVED THEREFROM7 moClosed
90/014,063Jan 10, 20188,314,225HEAVY CHAIN MUTANT LEADING TO IMPROVED IMMUNOGLOBULIN PRODUCTION50 moClosed
90/014,017Sep 29, 20179,040,052Precision Medicine by Targeting Rare Human PCSK9 Variants for Cholesterol Treatment26 moClosed
90/013,979Jul 10, 20178,951,523Targeting Rare Human PCSK9 Variants for Cholesterol Treatment19 moClosed

Other USPTO reexam examiners

Get the full reexam analytics

Compare Sharon L Turner against the full corpus, see the certificate-outcome split, drill into event timing, filter the case list, and export. Free to sign up.